medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 5

<< Back Next >>

Salud Mental 2005; 28 (5)

Assessment of depression, anxiety, and anger in HIV/AIDS patients.

Teva I, Bermúdez MP, Hernández-Quero J, Buela-Casal G
Full text How to cite this article

Language: Spanish
References: 33
Page: 40-49
PDF size: 98.72 Kb.


Key words:

Human Immunodeficiency Virus (HIV), Adquired Immunodeficiency Syndrome (AIDS), depression, anxiety, anger.

ABSTRACT

Introduction. HIV infection is a chronic-character illness which implies a high level of uncertainty for patients. Indeed, HIV infection involves confronting an illness surrounded by social stigma and refusal. There following are some of the situations that suppose big emotional repercussions: When an individual does not know whether he/she is infected, when he/she receives HIV diagnosis, or when he/she must say to other people that he/she is HIV positive. The emotional effects are depression, anxiety, and anger, which are frecuent emotional reactions among HIV infected patients. These reactions disappear when the patient adapts to his/her condition of HIV infected. Likewise, the uncertainty that produces HIV infection is related both to high levels of anxiety and depression because patients do not know how their infection will evolve. Anger and depression constitute other emotional factors related to a faster evolution of HIV infection. In addition to that, depression has effects over the fullfillment of the HIV infection treatment guidelines. Considering the importance of emotional aspects in HIV infection, this research's aims were to verify the differences in the sample of patients with HIV that has been evaluated regarding characteristics of depression, state of anxiety, state of anger, trait of anger, and expression of anger according to gender, stage of HIV infection, CD4 cells, viral load, transmission way, and the presence of lipodystrophy. Another aim was to verify if there were any differences between the sample of persons with HIV/AIDS that has been evaluated and the normative group in symptoms of depression, state of anxiety, state of anger, trait of anger, and expression of anger.
Method. In the present research paticipated 100 HIV/AIDS- infected patients; 37 of them were women and 63 were men. The patients attended medical visits in different hospitals of Andalusia (Spain). The age rank of these patients was between 18 and 70 years. The average age was 39.55 years and the standard deviation was 7.49. The instruments used for the assessment were the Beck Depression Inventory (BDI), the subscale of state of anxiety of the State-Trait Anxiety Inventory (STAI), and the State-Trait Anger Expression Inventory (STAXI-2). The data were collected in three hospitals of the Andalusian region by the same investigator and the confidentiality of the data was guaranteed. Another information collected were clinical data of the patients from the case histories. The statistic program SPSS 11.0 was used for the analysis of the data. This study has an ex post facto retrospective design.
Results. The results showed statistically significant differences in state of anxiety according to the viral load and lipodystrophy, with higher levels of state of anxiety in the group that had a halfway point in viral load and in the group that did not show lypodistrophy. On the other hand, there were statistically significant differences in the state of anger according to the stage of HIV infection, with higher levels of anger in the group that was in the symptomatic stage of HIV infection. In this study it has been found that most men with HIV/AIDS showed symptoms of depression that were between slight, moderate, and severe depression. In contrast, a big part of the group of women did not show characteristics of depression. With regard to anxiety, an important proportion of men showed a state of anxiety, while women did not show it in most cases. Most men and women presented a low level of state of anger. In the variable trait of anger, it has been found that approximately half of the men was in the normal rank. In the group of women, the majority was in the normal rank of trait of anger too. Finally, with regard to expression of anger, more of a third of the men and women with HIV/AIDS did not express anger.
Discussion. The stage of the HIV infection could be a factor that explains the high presence of characteristics of depression in men. Women could have better ways to confront the illness than men. The high levels of depression symptoms and anxiety in the group of men could be explained by the ignorance about how the infection will evolve. Other results indicated that patients infected by heterosexual relationships showed higher anxiety than patients infected by the intravenous use of drugs. This fact could be explained by a higher presence of cognitions related to the evolution of the HIV infection or risk behaviors in people who were infected by heterosexual intercourse. Patients with a halfway point in viral load showed higher levels of state of anxiety and state of anger than patients with low viral load, because people with halfway point in viral load were more aware of the deterioration produced by the HIV infection and they did not assume it. The stage of HIV infection could be a factor that explains the higher levels of state of anger in patients in the symptomatic stage. The presence of lipodystrophy implies a deterioration of corporal image in patients that suffer this syndrome. It has been found that patients who did not have lipodystrophy showed higher levels of state of anxiety than the patients with lipodystrophy. This result is incongruent with other studies that have been made. It is suggested that this is an effect of a small sample. However, two explanations can be advanced about this result. On the one hand, lipodystrophy has nowadays a subjective diagnosis, and it could be the case that many patients’ lipodystrophy has not being diagnosed, when they actually have the syndrome. On the other, it has been observed that there are delays when the data related to lipodystrophy must be gathered in case histories and thus it is not known if a patient endures lipodystrophy exactly. It could be the case that a patient suffers lipodystrophy and this fact does not appear in the case history.
Considering that depression and anxiety are frequent disorders in patients with HIV/AIDS and that these factors influence the immune system, the results obtained could be used for the design of intervention programs whose aims would be the assessment and the intervention of depression and anxiety. Some aspects which would be important to assess in future researches with HIV/AIDS patients are social support, levels of perceived stigma, and the perception of health control.


REFERENCES

  1. 1. BECK A, RUSH AJ, SHAW BF, EMERY G: Cognitive Therapy of Depression. Guilford Press. Nueva York, 1979.

  2. 2. BERMUDEZ J: Análisis funcional de la ansiedad. Rev Psicol Gen Apl, 153:617-634, 1978.

  3. 3. BERMUDEZ J: Ansiedad y rendimiento. Rev Psicol Gen Apl, 151:183-207, 1978.

  4. 4. BERMUDEZ MP, Teva I: Situación actual del SIDA en España: análisis de las diferencias entre comunidades autónomas. Int J Clin Health Psicol, 4:553-570, 2005.

  5. 5. CHURCH J: The application of cognitive-behavioural therapy for depression to people with Human Immunodeficiency Virus (HIV) and Acquired Immunedeficiency Syndrome (AIDS). Psychooncology, 7:78-88, 1998.

  6. 6. COLLINS E, WAGNER C, WALMSLEY S: Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader, 10:546-551, 2000.

  7. 7. GARCIA MD, FONT A: Evaluación de la calidad de vida en personas VIH positivas con lipodistrofia. Psicol Salud, 14:5-11, 2004.

  8. 8. GORDILLO V, DEL AMO J, SORIANO V, GONZALEZ-LAHOZ J: Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13:1763-1769, 1999.

  9. 9. HEINZE G: Mente-cerebro: sus señales y su repercusión en el sistema inmunológico. Salud Mental, 24:3-9, 2001.

  10. 10. HOLZEMER WL, CORLESS IB, NOKES KM, TURNER JG y cols.: Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care ST, 13:185-197, 1999.

  11. 11. KATZ MH, DOUGLAS JM, BOLAN GA, MARX R y cols.: Depression and use of mental health services among HIV-infected men. AIDS Care, 8:433-442, 1996.

  12. 12. LESERMAN J, PETITO JM, GU H, GAYNES BN: Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol Med, 32:1059-1073, 2002.

  13. 13. MARTIN I, CANO R, PEREZ DE AYALA P y cols.: Calidad de vida, aspectos psicológicos y sociales en pacientes con infección VIH avanzada. An Med Interna, 19:396-404, 2002.

  14. 14. MATUD P, CARBALLEIRA M, LOPEZ M, MARRERO R, IBAÑEZ I: Apoyo social y salud: un análisis de género. Salud Mental, 25:32-37, 2002.

  15. 15. MIGUEL-TOBAL JJ, CASADO MI, CANO-VINDEL A, SPIELBERGER CD: Manual del Inventario de Expresión de Ira Estado-Rasgo, STAXI-2. TEA Ediciones. Madrid, 2001.

  16. 16. MIGUEL-TOBAL JJ, GONZALEZ-ORDI H: Anxiety disorders. En: Fernández Ballesteros R (ed). Encyclopedia of Psychological Assessment. Sage: 40-44, Londres, 2003.

  17. 17. MOLASSIOTIS A, CALLAGHAN P, TWINN SF, LAM SW: A pilot study of the effects of cognitive-behavioral group therapy and peer support/counselling in decreasing psychological distress and improving quality of life in Chinese patients with symptomatic HIV disease. AIDS Patient Care ST, 16:83-96, 2002.

  18. 18. MONTERO I, LEON OG: Sistema de clasificación del método en los informes de investigación en psicología. Int J Clin Health Psychol, 5:115-127, 2005.

  19. 19. MOSCOSO MS, BERMUDEZ MP: Ira y hostilidad: evaluación e implicaciones en el tratamiento psicológico de pacientes infectados por VIH. En: Fernández-Abascal EG, Palmero F (coords). Emociones y Salud. Ariel, pp 233-250, Barcelona, 1999.

  20. 20. PAVON RL, HERNANDEZ ME, LORIA SF, SANDOVAL LG: Interacciones neuroendocrinoinmunológicas. Salud Mental, 27:19-25, 2004.

  21. 21. PENZAK SR, REDDY YS, GRIMSLEY SR: Depression in patients with HIV infection. Am J Health Syst Pharm, 57:376-386, 2000.

  22. 22. RAMOS-ALVAREZ MM, CATENA A: Normas para la elaboración y revisión de artículos originales experimentales en ciencias del comportamiento. Int J Clin Health Psychol, 4:173-189, 2004.

  23. 23. REMOR EA, CARROBLES JA, ARRANZ P, MARTINEZ DA, ULLA S: Ansiedad y percepción de control en la infección por VIH y SIDA. Psicol Conduct, 9:323-336, 2001.

  24. 24. SANZ J, VAZQUEZ C: Fiabilidad, validez y datos normativos del Inventario para la Depresión de Beck. Psicothema, 10:303-318, 1998.

  25. 25. SIEGEL K, KARUS D, RAVEIS VH, HAGEN D: Psychological adjustment of women with HIV/AIDS: racial and ethnic comparisons. J Community Psychol, 26:439-455, 1998.

  26. 26. SPIELBERGER CD: Manual for the State-Trait Anger Expression Inventory. Psychological Assessment Resources. Odessa, 1996.

  27. 27. SPIELBERGER CD, GORSUCH R, LUSCHENE R: Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press. California, 1970 (Adapt. Española, TEA, 1982).

  28. 28. SU L: Depression, antidepressant prescribing and quality of life in an urban HIV-infected population. Dissert Abst Int Section B Sciences Engineering, 57:3163, 1996.

  29. 29. TRUJILLO HM, OVIEDO-JOEKES E, VARGAS C: Avances en psiconeuroinmunología. Rev Int Psic Clín Salud/Int J Clin Health Psychol, 1:413-474, 2001.

  30. 30. VAN-SERVELLEN G, AGUIRRE M, SARNA L, BRECHT ML: Differential predictors of emotional distress in HIV-infected men and women. West J Nurs Res, 24:49-72, 2002.

  31. 31. VAZQUEZ C, SANZ J: Fiabilidad y valores normativos de la versión española del Inventario para la Depresión de Beck de 1978. Clínica Salud, 8:403-422, 1997.

  32. 32. VAZQUEZ C, SANZ J: Fiabilidad y validez de la versión española del Inventario para la Depresión de Beck de 1978, en pacientes con trastornos psicológicos. Clínica Salud, 10:59-81, 1999.

  33. 33. VERA-VILLARROEL P, PEREZ V, MORENO E, ALLENDE F: Diferencias en variables psicosociales en sujetos VIH homosexuales y heterosexuales. Int J Clin Health Psychol, 4:55-67, 2004.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2005;28